PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING LIVER CANCER, COMPRISING TETRAARSENIC HEXOXIDE CRYSTALLINE POLYMORPH

The present invention relates to a pharmaceutical composition for preventing or treating liver cancer and a method for producing same, the composition comprising tetraarsenic hexoxide in which the content of tetraarsenic hexoxide crystalline polymorph a (As4O6-a) is 99% or more. The composition of t...

Full description

Saved in:
Bibliographic Details
Main Authors BAE, Ill Ju, LIAN, Zenglin
Format Patent
LanguageEnglish
French
Korean
Published 14.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a pharmaceutical composition for preventing or treating liver cancer and a method for producing same, the composition comprising tetraarsenic hexoxide in which the content of tetraarsenic hexoxide crystalline polymorph a (As4O6-a) is 99% or more. The composition of the present invention exhibits an excellent cancer cell proliferation inhibition effect and thus can be useful as an anticancer drug. La présente invention concerne une composition pharmaceutique pour prévenir ou traiter le cancer du foie ainsi que son procédé de production, la composition comprenant un hexaoxyde de tétra-arsenic dans lequel la teneur en polymorphe cristallin d'hexaoxyde de tétra-arsenic a (As4O6-a) est de 99 % ou plus. La composition de la présente invention présente un excellent effet d'inhibition de la prolifération des cellules cancéreuses et peut donc être utile en tant que médicament anticancéreux. 본 발명은 육산화사비소의 결정다형 a(AsO6-a)가 99% 이상인 육산화사비소를 포함하는 간암 예방 또는 치료용 약학 조성물 또는 이의 제조방법에 관한 것으로서, 본 발명의 조성물은 우수한 암세포 증식 억제 효과를 나타내어 항암제로 유용하게 이용될 수 있다.
Bibliography:Application Number: WO2017KR14083